TY - JOUR
T1 - Pathologic features of early inflammatory bowel disease
AU - Finkelstein, Sydney D.
AU - Sasatomi, Eizaburo
AU - Regueiro, Miguel
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Often the pathologic changes of IBD are subtle and may not be present in a proportion of biopsy specimens. In cases of early disease, the changes may be missed, and additional specimens should be taken after a period of time. Modifying factors, such as prebiopsy treatment and coexisting disease, should be considered. A forum to review cases and allow for communication between gastroenterologists and pathologists is especially useful for clinico- pathologic correlation and assignment of a working diagnosis to each case. Careful attention to the pathologic features of early UC and CD would be most useful when evaluating new therapies for IBD.
AB - Often the pathologic changes of IBD are subtle and may not be present in a proportion of biopsy specimens. In cases of early disease, the changes may be missed, and additional specimens should be taken after a period of time. Modifying factors, such as prebiopsy treatment and coexisting disease, should be considered. A forum to review cases and allow for communication between gastroenterologists and pathologists is especially useful for clinico- pathologic correlation and assignment of a working diagnosis to each case. Careful attention to the pathologic features of early UC and CD would be most useful when evaluating new therapies for IBD.
UR - http://www.scopus.com/inward/record.url?scp=0035986131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035986131&partnerID=8YFLogxK
U2 - 10.1016/S0889-8553(01)00009-7
DO - 10.1016/S0889-8553(01)00009-7
M3 - Article
C2 - 12122728
AN - SCOPUS:0035986131
SN - 0889-8553
VL - 31
SP - 133
EP - 145
JO - Gastroenterology Clinics of North America
JF - Gastroenterology Clinics of North America
IS - 1
ER -